Specifically, SAB has been shown to regulate glycolysis through the PI3K/AKT/HIF-1α signaling pathway, thereby inhibiting metabolic reprogramming and tumor growth in a hamster oral cancer model (Wei et al., 2018). Here, PIK3CA is linked to lip and oral cavity carcinoma.